Pediatric relapsed acute myeloid leukemia: a systematic review

Keyphrases

• Pediatric 100%
• Relapsed or Refractory Acute Myeloid Leukemia 100%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 50%
• Prognostic Factors 50%
• Randomized Clinical Trial 50%
• Clinical Outcomes 33%
• Overall Survival Rate 33%
• Intensive Care Medicine 16%
• First Relapse 16%
• Event-free Survival 16%
• Risk Stratification 16%
• Overall Survival 16%
• PubMed 16%
• International Collaboration 16%
• Late Effects 16%
• Embase 16%
• Second Complete Remission 16%
• Randomized Trial 16%
• Chemotherapy-only 16%
• First Complete Remission 16%
• Treatment Outcome 16%
• Expert Opinion 16%
• Induction Chemotherapy 16%
• Independent Prognostic Factor 16%
• Disease-free Survival 16%
• Less Toxic 16%
• Survival Events 16%
• Optimal Therapy 16%
• Consolidation Therapy 16%
• Area Cover 16%
• Incomplete Knowledge 16%
• Chemotherapy Duration 16%
• Stratified Treatment 16%

Medicine and Dentistry

• Pediatrics 100%
• Acute Myeloid Leukemia 100%
• Systematic Review 100%
• Prognostic Factor 66%
• Overall Survival 50%
• Randomized Clinical Trial 50%
• Survival Rate 33%
• Chemotherapy 33%
• Event Free Survival 16%
• Intensive Care 16%
• Late Effect 16%
• Leukemia in Children 16%
• Disease Free Survival 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Myeloid Leukemia 100%
• Overall Survival 50%
• Randomized Clinical Trial 50%
• Chemotherapy 33%
• Remission 33%
• Survival Rate 33%
• Event Free Survival 16%
• Disease Free Survival 16%